Therma Bright’s International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology
BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer
